PATENT CLAIM ANALYSIS

Application Number: 16009303
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "04400A"]

Abstract:
The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoural or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.

Claim (Index 8):
The method according to  claim 1 , wherein said oligonucleotide is at least one molecule of natural nucleic acid, at least one molecule of natural nucleic acid chemically modified, or at least one molecule of synthetic nucleic acid selected from PNA, LNA or morpholino, at least one molecule of synthetic nucleic acid chemically modified or a combination of said natural nucleic acid and said synthetic nucleic acid.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 94.0
- Lexical Diversity: 1.65714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14780043', '14533371', '15882221', '15364050', '15222695']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7341224501618265
- 35 USC 102 Novelty (BERT): 0.5022051529589256
- Combined Prediction Score: 0.7109307204415365
- Mean Citation Score: 236.347142
- Max Citation Score: 246.64674
- Similarity Product: 193.29228428514003

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test